Neurogenic stunned myocardium is an uncommon event after neurosurgical procedures in children. Pediatric intensivists need to consider this diagnosis in a patient with signs of myocardial dysfunction in the neurosurgical postoperative period. The management of neurogenic stunned myocardium involves close monitoring and establishing the absence of other causes of myocardial ischemia.
A 12-year-old boy with systemic lupus erythematosus and lupus nephritis was admitted to the hospital with his third episode of pneumonia in six weeks. Prior to admission, he had received four courses of cytoxan and had been chronically taking prednisone. Cefotaxime was started on admission, until the second hospital day when a urine culture grew enterococcus. Antibiotic therapy was then changed to vancomycin and gentamicin. On the sixth hospital day, the patient developed septic shock and he was transferred to the pediatric intensive care unit (PICU). A blood culture from admission grew fungus and the enterococcus that grew from the urine proved to be resistant to vancomycin. In the PICU, he had a heart rate of 120 and was tachypneic with a respiratory rate in the 40's. A blood pressure was unable to be obtained. He was lethargic and had poor peripheral perfusion. He was placed on broader spectrum antibiotics and antifungal medications. The patient was subsequently intubated for respiratory failure and received aggressive fluid resuscitation. He required increasing inotropic support, including epinephrine, dopamine, dobutamine, vasopressin, and norepinphrine before a blood pressure of 80's/40's could be obtained. Stress dose steroids were administered. He also received intravenous immunoglobulin. Despite escalating doses of multiple vasopressors, the patient's hemodynamic status continued to deteriorate. The patient suffered a cardiac arrest and was not able to be resuscitated. Two days following his death, Cryptococcus neoformans was identified from the initial blood culture. Cryptococcus neoformans was recovered from the lymph nodes, spleen, and lungs on autopsy. Post-mortem findings also showed a hemorrhagic pneumonitis due to Cryptococcus neoformans.
A 12-year-old boy with systemic lupus erythematosus and lupus nephritis was admitted to the hospital with his third episode of pneumonia in six weeks. Prior to admission, he had received four courses of cytoxan and had been chronically taking prednisone. Cefotaxime was started on admission, until the second hospital day when a urine culture grew enterococcus. Antibiotic therapy was then changed to vancomycin and gentamicin. On the sixth hospital day, the patient developed septic shock and he was transferred to the pediatric intensive care unit (PICU). A blood culture from admission grew fungus and the enterococcus that grew from the urine proved to be resistant to vancomycin. In the PICU, he had a heart rate of 120 and was tachypneic with a respiratory rate in the 40's. A blood pressure was unable to be obtained. He was lethargic and had poor peripheral perfusion. He was placed on broader spectrum antibiotics and antifungal medications. The patient was subsequently intubated for respiratory failure and received aggressive fluid resuscitation. He required increasing inotropic support, including epinephrine, dopamine, dobutamine, vasopressin, and norepinphrine before a blood pressure of 80's/40's could be obtained. Stress dose steroids were administered. He also received intravenous immunoglobulin. Despite escalating doses of multiple vasopressors, the patient's hemodynamic status continued to deteriorate. The patient suffered a cardiac arrest and was not able to be resuscitated. Two days following his death, Cryptococcus neoformans was identified from the initial blood culture. Cryptococcus neoformans was recovered from the lymph nodes, spleen, and lungs on autopsy. Post-mortem findings also showed a hemorrhagic pneumonitis due to Cryptococcus neoformans.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.